Akyuz Muhammet, Aucejo Federico, Quintini Cristiano, Miller Charles, Fung John, Berber Eren
Department of General Surgery, Cleveland Clinic, Cleveland, Ohio, USA.
Gland Surg. 2016 Jun;5(3):263-9. doi: 10.21037/gs.2015.12.03.
Hepatic recurrence after resection of colorectal liver metastasis (CLM) occurs in 50% of patients during follow-up, with 2.8% to 13.9% presenting with surgical margin recurrence (SMR). The aim of this study is to analyze factors that related to SMR in patients with CLM undergoing hepatectomy.
Demographics, clinical and survival data of patients who underwent hepatectomy were identified from a prospectively maintained, institutional review board (IRB)-approved database between 2000 and 2012. Statistical analysis was performed using univariate Kaplan Meier and Cox proportional hazard model.
There were 85 female and 121 male patients who underwent liver resection for CLM. An R0 resection was performed in 157 (76%) patients and R1 resection in 49. SMR was detected in 32 patients (15.5%) followed up for a median of 29 months (range, 3-121 months). A half of these patients had undergone R1 (n=16) and another half R0 resection (n=16). Tumor size, preoperative carcinoembryonic antigen (CEA) level and margin status were associated with SMR on univariate analysis. On multivariate analysis, a positive surgical margin was the only independent predictor of SMR. The receipt of adjuvant chemotherapy did not affect margin recurrence. SMR was an independent risk factor associated with worse disease-free (DFS) and overall survival (OS).
This study shows that SMR, which can be detected in up to 15.5% of patients after liver resection for CLM, adversely affects DFS and OS. The fact that a positive surgical margin was the only predictive factor for SMR in these patients underscores the importance of achieving negative margins during hepatectomy.
结直肠癌肝转移(CLM)切除术后肝复发在50%的患者随访期间出现,2.8%至13.9%的患者出现手术切缘复发(SMR)。本研究的目的是分析接受肝切除术的CLM患者中与SMR相关的因素。
从2000年至2012年前瞻性维护、经机构审查委员会(IRB)批准的数据库中识别接受肝切除术患者的人口统计学、临床和生存数据。使用单变量Kaplan Meier和Cox比例风险模型进行统计分析。
有85名女性和121名男性患者因CLM接受肝切除术。157例(76%)患者进行了R0切除,49例进行了R1切除。在32例患者(15.5%)中检测到SMR,中位随访时间为29个月(范围3 - 121个月)。这些患者中有一半接受了R1切除(n = 16),另一半接受了R0切除(n = 16)。单变量分析显示肿瘤大小、术前癌胚抗原(CEA)水平和切缘状态与SMR相关。多变量分析显示,手术切缘阳性是SMR的唯一独立预测因素。辅助化疗的使用不影响切缘复发。SMR是与无病生存期(DFS)和总生存期(OS)较差相关的独立危险因素。
本研究表明,CLM肝切除术后高达15.5%的患者可检测到SMR,这对DFS和OS有不利影响。手术切缘阳性是这些患者中SMR的唯一预测因素,这一事实强调了肝切除术中实现切缘阴性的重要性。